Turn Therapeutics (TTRX) CEO-linked entity gifts 300,000 shares, retains 15.7M

Rhea-AI Filing Summary

Turn Therapeutics Inc. director and Chief Executive Officer Burnam Bradley Evan reported a bona fide gift of 300,000 shares of common stock, carried out through BEB Holdings, LLC, an entity he solely controls. The gift involved no sale proceeds, with a reported price of $0.00 per share. Following this indirect disposition, BEB Holdings, LLC, which is deemed beneficially owned by Burnam Bradley Evan due to his sole voting and dispositive power, held 15,716,260 shares of Turn Therapeutics common stock.

Insights

Equity compensation and insider-transactions analyst

CEO’s 300,000-share gift via LLC is a non-cash, routine disposition with large holdings remaining.

The filing shows a bona fide gift of 300,000 Turn Therapeutics common shares by BEB Holdings, LLC, an entity solely controlled and beneficially owned by CEO and director Burnam Bradley Evan. The transaction code G and reported price of $0.00 per share confirm this is not a market sale.

After the gift, BEB Holdings, LLC still holds 15,716,260 shares, which are deemed beneficially owned by Burnam Bradley Evan due to his sole voting and dispositive power. Given the non-cash nature and substantial remaining stake, this filing reads as a routine personal estate or gifting move rather than a shift in outlook, so its investment impact is neutral based on the disclosed data.

Insider Trade Summary

300,000 shares gifted

Mixed 1 txn

Insider Burnam Bradley Evan, BEB Holdings, LLC

Role Chief Executive Officer | 10% Owner

Type	Security	Shares	Price	Value
Gift	Common Stock	300,000	$0.00	--

Holdings After Transaction: Common Stock — 15,716,260 shares (Indirect, By BEB Holdings, LLC)

Footnotes (1)

1. [object Object]

Key Figures

Gifted shares: 300,000 shares Post-transaction holdings: 15,716,260 shares Gift price per share: $0.00 per share

3 metrics

Gifted shares 300,000 shares Bona fide gift of common stock (code G)

Post-transaction holdings 15,716,260 shares Common stock held by BEB Holdings, LLC after gift

Gift price per share $0.00 per share Reported transaction price for gifted common stock

Key Terms

bona fide gift, beneficially owned, dispositive power

3 terms

bona fide gift financial

"The transaction code G is described as a bona fide gift."

beneficially owned financial

"all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

dispositive power financial

"has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burnam Bradley Evan

(Last) (First) (Middle)

C/O TURN THERAPEUTICS INC.

250 N. WESTLAKE BLVD.

(Street)

WESTLAKE VILLAGE CALIFORNIA 91362

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Turn Therapeutics Inc. [ TTRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		G		300,000	D	$0	15,716,260	I	By BEB Holdings, LLC(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Burnam Bradley Evan

(Last) (First) (Middle)

C/O TURN THERAPEUTICS INC.

250 N. WESTLAKE BLVD.

(Street)

WESTLAKE VILLAGE CALIFORNIA 91362

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

1. Name and Address of Reporting Person^*

BEB Holdings, LLC

(Last) (First) (Middle)

C/O TURN THERAPEUTICS INC.

250 N. WESTLAKE BLVD.

(Street)

WESTLAKE VILLAGE CALIFORNIA 91362

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Represents shares of common stock held by BEB Holdings, LLC. The reporting person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC. Accordingly, all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person.

	/s/ Zuraiz Chaudhary, attorney-in-fact for Bradley Burnam	04/03/2026
	/s/ Bradley Burnam, sole member of BEB Holdings, LLC	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Turn Therapeutics (TTRX) report in this Form 4?

Turn Therapeutics reported that BEB Holdings, LLC, an entity solely controlled by CEO and director Burnam Bradley Evan, made a bona fide gift of 300,000 common shares. The filing classifies the move as a gift transfer, not an open-market trade or sale.

Was the Turn Therapeutics (TTRX) Form 4 transaction a stock sale or purchase?

The Form 4 shows no stock sale or purchase. Instead, it records a bona fide gift of 300,000 common shares at a reported price of $0.00 per share, meaning there was no cash consideration and no open-market trading involved.

How many Turn Therapeutics (TTRX) shares remain held after the CEO’s reported gift?

Following the 300,000-share gift, BEB Holdings, LLC is reported as holding 15,716,260 common shares. Because CEO Burnam Bradley Evan is the sole member with sole voting and dispositive power, these shares may be deemed beneficially owned by him.

Who is BEB Holdings, LLC in relation to Turn Therapeutics (TTRX) insider ownership?

BEB Holdings, LLC is an entity whose sole member is Burnam Bradley Evan, Turn Therapeutics’ CEO and director. The filing states he has sole voting and dispositive power over shares held by BEB Holdings, LLC, so those shares may be deemed beneficially owned by him.

What does transaction code G mean in the Turn Therapeutics (TTRX) Form 4?

Transaction code G on the Form 4 indicates a bona fide gift. In this case, it reflects a non-cash transfer of 300,000 Turn Therapeutics common shares by BEB Holdings, LLC, rather than a market sale, purchase, or option exercise transaction.